With reports of Nimesulide causing liver toxicity red-flagged, the Drug Controller General of India (DCGI) has asked the manufacturers to add “box warning” on its label, suggesting that its use to be restricted to 10 days and if longer clinical use is necessary then liver function test should be assessed periodically. The health ministry had earlier last year banned the paediatric use of the analgesic Nimesulide after the sub committee of the government’s chief advisory body-the Drug Technical Advisory Board (DTAB) recommended for the same.